Lithuania secures 1.8m coronavirus vaccine doses under EC deal
The European Commission has signed a contract with the British-Swedish pharmacy company AstraZeneca for the supply of at least 300 million doses of Covid-19 vaccine it is developing.
“Through the contract, all member states will be able to purchase 300 million doses of the AstraZeneca vaccine, with an option for further 100 million doses, to be distributed on a population-based pro-rata basis,” the EC has said in a press release.
Lithuanian Health Minister Aurelijus Veryga posted on his personal Facebook page that Lithuania would get “just over 1.8 million doses of the vaccine”.
“Lithuania […] will receive the vaccine against this insidious virus if the clinical trials are successful and as soon as it is manufactured,” he added.
The Commission continues talks with other vaccine manufacturers and is likely to sign contracts with Sanofi-GSK, Johnson & Johnson, CureVac and Moderna shortly, according to Veryga.
AstraZeneca said on Tuesday that it had started clinical trials of an antibody combination called AZD7442, which is being developed for the prevention and treatment of Covid-19.
The trial includes up to 48 healthy participants aged 18–55 and will assess the safety and tolerability of the drug.
“The treatment has the potential to be given as a preventative option for people exposed to the virus, and to treat and prevent disease progression in patients already infected by the virus,” the company said in a press release.
The results of the trials are expected by the end of 2020.